Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Quercetin in culture with pathogens exerts anti‐pathogenic activities, but little is known regarding quercetin's effects on upper respiratory tract infection rates (URTI). The purpose of this randomized, double‐blinded, placebo‐controlled trial was to measure the influence of two quercetin doses (500 and 1000 mg/day) compared to placebo on URTI rates in a community group (N=1002, ages 18 to 85 years). Subjects ingested supplements for 12 weeks and logged URTI symptoms on a daily basis using the Wisconsin Upper Respiratory Symptom Survey. No significant group differences were measured for URTI outcomes, or when analyzing separately by gender, BMI, and age categories. Regression analysis revealed that the strongest interaction effect with group status was self‐reported fitness level. A separate analysis of subjects ≥ 40 years of age rating themselves in the top half of the entire group for fitness level (N=325) showed lower URTI severity (36% reduction, P=0.020) and URTI total sick days (31% reduction, P=0.048) for the Q‐1000 group compared to placebo In summary, quercetin supplementation over 12 weeks had no significant influence on URTI rates or symptomatology compared to placebo for all subjects combined. A reduction in URTI was experienced in subjects ≥ 40 years of age ingesting 1000 mg quercetin/day and rating themselves as physically fit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychological Stress and Susceptibility to the Common Cold
Cohen, S., Tyrrell, D. A. J., & Smith, A. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108293250903 · Cited by 1,712 · cited 2×
“Based on these study results, we hypothesized that longterm quercetin supplementation would reduce URTI incidence and symptomatology in the general community, especially among high-risk groups such as young adult females and other individuals with risk factors for URTI such as obesity, poor physical fitness, or high l…”
Vitamin C for preventing and treating the common cold
Hemilä, H., & Chalker, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000980.pub4 · Cited by 869
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768 · cited 2×
“[2] Mäkelä MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimäki M, et al.”
Acute respiratory illness in the community: frequency of illness and the agents involved
Monto, A. S., & Sullivan, K. M. (1993) · Epidemiology and Infection · doi:10.1017/s0950268800050779 · Cited by 458
Physical activity and immune function in elderly women
NIEMAN, D. C., HENSON, D. A., GUSEWITCH, G., WARREN, B. J., DOTSON, R. C., BUTTERWORTH, D. E., & NEHLSEN-CANNARELLA, S. L. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199307000-00011 · Cited by 393 · cited 2×
“Based on these study results, we hypothesized that longterm quercetin supplementation would reduce URTI incidence and symptomatology in the general community, especially among high-risk groups such as young adult females and other individuals with risk factors for URTI such as obesity, poor physical fitness, or high l…”
Self-citationQuercetin Reduces Illness but Not Immune Perturbations after Intensive Exercise
NIEMAN, D. C., HENSON, D. A., GROSS, S. J., JENKINS, D. P., DAVIS, J. M., MURPHY, E. A., CARMICHAEL, M. D., DUMKE, C. L., UTTER, A. C., MCANULTY, S. R., et al. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318076b566 · Cited by 193 · cited 2×
“A double-blind, placebo-controlled study with 40 cyclists, in which immune function was analyzed in parallel with incidence and severity of URTI, was conducted by our research team [12] .”
Self-citationThe Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid
BARRETT, B., BROWN, R., MUNDT, M., SAFDAR, N., DYE, L., MABERRY, R., & ALT, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.11.019 · Cited by 173 · cited 2×
“The construct validity of the WURSS has been supported by measures of reliability, responsiveness, importance to patients, and convergence [21] .”
Cited by
Quercetin, Inflammation and Immunity
Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M., Wang, S., Liu, H., & Yin, Y. (2016) · Nutrients · doi:10.3390/nu8030167 · Cited by 1,999
“Quercetin (100 mg/day) did not alter exercise-induced changes in several measures of immune function following three days of intense exercise in trained athletes, but it significantly reduced URTI incidence (1 of 20 subjects in active versus 9 of 20 in placebo group) during the two-week post-exercise period [74].”
InfluentialNrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
Overviews of biological importance of quercetin: A bioactive flavonoid
Parasuraman, S., Anand David, A., & Arulmoli, R. (2016) · Pharmacognosy Reviews · doi:10.4103/0973-7847.194044 · Cited by 1,610
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
Safety Aspects of the Use of Quercetin as a Dietary Supplement
Andres, S., Pevny, S., Ziegenhagen, R., Bakhiya, N., Schäfer, B., Hirsch‐Ernst, K. I., & Lampen, A. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700447 · Cited by 588
Metadata
- Authors
- Heinz, S. A., Henson, D. A., Austin, M. D., Jin, F., & Nieman, D. C.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 62
- Issue
- 3
- Pages
- 237-242
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2053935131
- Cited by
- 152
- References
- 7
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. https://app.cochat.ai/papers/10.1016/j.phrs.2010.05.001
- The paper
- Heinz, S. A., Henson, D. A., Austin, M. D., Jin, F., & Nieman, D. C. (2010). Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacological Research. https://doi.org/10.1016/j.phrs.2010.05.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.